Lisa Argnani

17PUBLICATIONS
46CO-AUTHORS
Immunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Haematological tumoursRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Feb 13, 2026
Analytical and clinical performance of in-house and commercial real-time PCR assays for diagnosing L. infantum visceral leishmaniasis: a study from a hub center in Northern Italy.

Tommaso Gritti, Beatrice Mola, Lisa Argnani

|Jan 14, 2026
TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B-Cell Lymphoma in the Real-Life Patient Journey.

Lisa Argnani, Cinzia Pellegrini, Ombretta Annibali

|Aug 06, 2024
Role of gut microbiome in the outcome of lymphoma patients treated with checkpoint inhibitors-The MicroLinf Study.

Beatrice Casadei, Gabriele Conti, Monica Barone

|May 02, 2024
Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activity.

Rossana Di Staso, Beatrice Casadei, Marianna Gentilini

|Feb 15, 2022
Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study.

Beatrice Casadei, Lisa Argnani, Alessandro Broccoli

|Feb 03, 2022
Immune-related adverse events in the treatment of non-Hodgkin lymphoma with immune checkpoint inhibitors.

Lisa Argnani, Beatrice Casadei, Carla Pelusi

Pageof 3

Frequent Collaborators

11 joint publications

Pier Luigi Zinzani

2 joint publications

Alessandro Broccoli

1 joint publications

G Carrara

1 joint publications

A Zanetti